Literature DB >> 8709643

Detection of HHV-8/KSHV DNA sequences in AIDS-associated extranodal lymphoid malignancies.

T Otsuki1, S Kumar, B Ensoli, D W Kingma, T Yano, M Stetler-Stevenson, E S Jaffe, M Raffeld.   

Abstract

Herpesvirus-like DNA sequences have been identified in a high proportion of both AIDS-associated and classical Kaposi's sarcoma, and in a small percentage of AIDS-associated malignant lymphomas. To determine the extent of involvement of this new agent designated HHV-8 (human herpesvirus type 8) or KSHV (Kaposi's sarcoma-associated herpesvirus) in human malignant lymphomas, we analyzed 24 AIDS-associated lymphoid malignancies and 100 non-AIDS-associated lymphomas by PCR and Southern blot analysis. Three of 24 lymphoid malignancies from patients with AIDS demonstrated HHV-8 sequences by Southern blot and PCR analyses. The fourth was positive by PCR only. None of the non-AIDS-associated lymphomas contained HHV-8 sequences. All three Southern blot positive samples were derived from extranodal regions, two from pleural effusions, and one from a soft tissue mass in the thigh. This latter patient initially presented with a pleural effusion. The fourth PCR positive but Southern blot negative tumor was from a gingival lymphoma in a patient with a history of Kaposi's sarcoma. All tumors positive for HHV-8 were also positive for EBV. These results confirm a recent report that this novel herpesvirus may play a role in AIDS-associated lymphomas especially in those with body cavity presentation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8709643

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  18 in total

1.  Lymphoid disorders associated with HHV-8/KSHV infection: facts and contentions.

Authors:  G Gaidano; E Castaños-Velez; P Biberfeld
Journal:  Med Oncol       Date:  1999-04       Impact factor: 3.064

2.  Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.

Authors:  A J Aguirre; E S Robertson
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Polymerase chain reaction detection of Kaposi's sarcoma-associated herpesvirus-optimized protocols and their application to myeloma.

Authors:  L Pan; L Milligan; J Michaeli; E Cesarman; D M Knowles
Journal:  J Mol Diagn       Date:  2001-02       Impact factor: 5.568

4.  Rhesus rhadinovirus R15 encodes a functional homologue of human CD200.

Authors:  Carly L Langlais; John M Jones; Ryan D Estep; Scott W Wong
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

5.  Molecular pathology of primary intraocular lymphoma.

Authors:  Chi-Chao Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2003

Review 6.  Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases.

Authors:  Dharam V Ablashi; Louise G Chatlynne; James E Whitman; Ethel Cesarman
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

7.  Establishment of a primary effusion lymphoma cell line (RM-P1) and in vivo growth system using SCID mice.

Authors:  Jun-ichi Miyagi; Masato Masuda; Nobuyuki Takasu; Akitoshi Nagasaki; Tetsuharu Shinjyo; Hiroshi Uezato; Naoki Kakazu; Yuetsu Tanaka
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 8.  Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders.

Authors:  M-Q Du; C M Bacon; P G Isaacson
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

9.  Drug sensitivity patterns of HHV8 carrying body cavity lymphoma cell lines.

Authors:  Rita Otvös; Henriette Skribek; Lorand L Kis; Annunziata Gloghini; Laszlo Markasz; Emilie Flaberg; Staffan Eksborg; Jozsef Konya; Lajos Gergely; Antonino Carbone; Laszlo Szekely
Journal:  BMC Cancer       Date:  2011-10-12       Impact factor: 4.430

10.  Lack of involvement of known oncogenic DNA viruses in Epstein-Barr virus-negative Hodgkin's disease.

Authors:  A A Armstrong; L Shield; A Gallagher; R F Jarrett
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.